While ICRF-193 suppressed tumor growth, <i>Top2β<sup>f/f</sup></i> deficiency (with a compensatory TOP2α upregulation) enhanced tumor development, indicating potential roles for TOP2 isozymes in tumor formation and progression. The gene discussed is TOP2B; the disease is neoplasm.